Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list

CardioVascular and Interventional Radiology

Volumn 34, Issue 6, 2011, Pages 1254-1261

  Frangakis, Constantine ^a   Geschwind, Jean Francois ^b   Kim, Daniel ^b   Chen, Yong ^a   Koteish, Ayman ^b   Hong, Kelvin ^b   Liapi, Eleni ^b   Georgiades, Christos S ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chemoembolization; Drop off risk; HCC; Liver transplantation; Milan criteria

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONTROLLED STUDY; DROP OFF RISK; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; SURVIVAL RATE; TUMOR NUMBER; TUMOR VOLUME;

ACRYLIC RESINS; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHIODIZED OIL; FEMALE; FOLLOW-UP STUDIES; GELATIN; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROPENSITY SCORE; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84856761893     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-0077-7     Document Type: Article

References (31)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699 (Pubitemid 26079803)
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394-1403 (Pubitemid 32496976)
3. Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD et al (2009) An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl 15(8):859-868
4. Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, Mayrger GR (2007) Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol 30:888-893 (Pubitemid 47497868)
5. Obed A, Beham A, Püllmann K, Becker H, Schlitt HJ, Lorf T (2007) Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. World J Gastroenterol 13(5):761-767
6. Kim DY, Moon-Choi S, Lee JH, Koh KC, Paik SW, Yoo BC et al (2006) Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. World J Gastroenterol 12(43):6992-6997 (Pubitemid 44834890)
7. Wiesner R, Freeman RB, Mulligan DC (2004) Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 127(Suppl):S261-S267 (Pubitemid 39423395)
8. Chapman WC, Majella-Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD et al (2008) Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 248(4):617-625
9. Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C et al. (2007) Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transplant 13:665-671 (Pubitemid 46796537)
10. Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R et al (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transplant 13:272-279 (Pubitemid 46351654)
11. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S et al (2006) Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203:411-420 (Pubitemid 44416253)
12. http://optn.transplant.hrsa.gov/latestData/rptData.asp. Accessed 1 Nov 2010
13. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35(5):1164-1171 (Pubitemid 34454013)
14. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37(2):429-442 (Pubitemid 36152543)
15. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224(1):47-54 (Pubitemid 34680374)
16. Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W et al (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transplant 9(6):557-563 (Pubitemid 36701690)
17. Otto G, Herber S, Heise M, Lohse AW, Monch C, Bittinger F et al (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transplant 12:1260-1267 (Pubitemid 44194595)
18. Sotiropoulos GC, Malago M, Molmenti EP, Radtke A, Brokalaki EI, Nadalin S et al (2005) Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res 10(12):539-542 (Pubitemid 43009573)
19. Saborido BP, Meneu JC, Moreno E, García I, Moreno A, Fundora Y (2005) Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 190:383-387 (Pubitemid 41139290)
20. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F et al (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transplant 11:767-775 (Pubitemid 40975578)
21. Otto G, Heise M, Moench C, Herber S, Bittinger F, Schuchmann M et al (2007) Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma. Transplant Proc 39:537-539 (Pubitemid 46386210)
22. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F et al (2007) Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transplant Int 20(9):747-753 (Pubitemid 47221058)
23. Aloia TA, Adam R, Samuel D, Azoulay D, Castaing DA (2007) Decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. J Gastrointest Surg 11:1328-1332
24. Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observation studies for causal effects. Biometrika 79:516-524
25. Rosenbaum PR (1984) Conditional permutation tests and the propensity score in observational studies. J Am Stat Assoc 79:565-574
26. Marchesini G, Moscatiello S, Di Domizio S, Forlani G (2008) Obesity-associated liver disease. J Clin Endocrinol Metab 93(11 Suppl 1):S74-S80
27. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S97-S103 (Pubitemid 39423375)
28. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ et al (2006) Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 43(2):345-351
29. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT et al (2008) Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359(10):1018-1026
30. Gotthardt D, Weiss KH, Baumgartner M, Zahn A, Stremmel W, Schmidt J et al (2009) Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 9:72
31. Ioannou G, Perkins JD, Carithers RL Jr (2008) Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 134(5):1342-1351 (Pubitemid 351615357)